Study guide
4.1 Sepsis, Severe Sepsis & Septic Shock Resuscitation
IBSC CCP-C Certified Critical Care Paramedic Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Strategy
1.1 About the CCP-C Exam 1.2 CCP-C Study Strategy & Exam Tactics
2 Chapter 2: Transport and Safety (Part 1)
2.1 Crew Resource Management & Sterile Cockpit Rule 2.2 Transport Risk Assessment & Mission Decision-Making 2.3 Aircraft and Ground Transport Safety Protocols
3 Chapter 2: Transport and Safety (Part 2)
2.4 Environmental Transport Stressors & Gas Laws 2.5 Transport Equipment Management & Post-Mission Operations
4 Chapter 3: Airway, Anesthesia, and Analgesics (Part 1)
3.1 Advanced Airway Assessment & Difficult Airway Identification 3.2 Rapid Sequence Induction (RSI) - Pretreatment & Induction Agents 3.3 Neuromuscular Blockade - Depolarizing vs Non-Depolarizing Agents 3.4 Post-Intubation Sedation, Analgesia & Dissociative Maintenance 3.5 Transport Ventilator Setup & Primary Ventilation Modes
5 Chapter 3: Airway, Anesthesia, and Analgesics (Part 2)
3.6 Mechanical Ventilator Waveforms, Loops & Oxygenation Titration 3.7 Ventilator Alarm Troubleshooting & Peak vs Plateau Pressures 3.8 Rescue Airway Devices, Video Laryngoscopy & Surgical Cricothyrotomy 3.9 Neuromuscular Reversal & Vasoactive Airway Support 3.10 Transport Airway Management in Unique Environments & Extubation
6 Chapter 4: General Medical Patient
4.1 Sepsis, Severe Sepsis & Septic Shock Resuscitation 4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm) 4.3 Renal and Hepatic Emergencies in Transport
7 Chapter 5: Cardiac Patient
5.1 Acute Coronary Syndromes & Infarct Specific Complications 5.2 Invasive Hemodynamic Monitoring 5.3 Vasoactive & Inotropic Medication Titration 5.4 Mechanical Circulatory Support & Post-Cardiac Arrest Care
8 Chapter 6: Neurological Patient
6.1 Traumatic Brain Injury & Intracranial Pressure (ICP) Management 6.2 Acute Ischemic Stroke, Hemorrhagic Stroke & Subarachnoid Hemorrhage 6.3 Status Epilepticus, Spinal Cord Injury & Neurogenic Shock
9 Chapter 7: Respiratory Patient
7.1 Acute Respiratory Distress Syndrome (ARDS) & Lung-Protective Ventilation 7.2 Severe Asthma & COPD Exacerbations in Critical Care 7.3 Chest Tube Management, Pleural Drains & Tension Pneumothorax 7.4 Pulmonary Embolism, Pulmonary Hypertension & Transport Respiratory Meds
10 Chapter 8: Toxic Exposure and Environmental Patient
8.1 Toxicology Emergencies, Toxidromes & Antidote Therapy 8.2 Environmental Emergencies (Hypothermia, Hyperthermia, Frostbite) 8.3 Submersion, Diving Emergencies & Envenomation/HazMat
11 Chapter 9: Trauma and Burn Patient
9.1 Hemorrhagic Shock Resuscitation & Massive Transfusion Protocols (MTP) 9.2 Severe Thoracic & Abdominal Trauma Management 9.3 Thermal, Chemical & Electrical Burn Assessment & Fluid Resuscitation 9.4 Musculoskeletal Trauma, Pelvic Fractures & Compartment Syndrome
12 Chapter 10: Maternal and Fetal Medicine
10.1 High-Risk Obstetric Assessment & Hypertensive Disorders of Pregnancy 10.2 Obstetric Hemorrhage, Placental Abruption & Preterm Labor 10.3 Emergency Transport Delivery, Umbilical Cord Prolapse & Fetal Monitoring
13 Chapter 11: Pediatric Patient
11.1 Pediatric Critical Care Airway & Transport Ventilation 11.2 Pediatric Shock, Dehydration & Weight-Based Dosing 11.3 Neonatal Resuscitation Program (NRP) & Transport of the Critical Neonate
14 Chapter 12: Special Populations
12.1 Bariatric Critical Care Transport & Positional Management 12.2 Geriatric Critical Care & Patients with Specialized Medical Technology
15 Chapter 13: Professional Considerations
13.1 Legal Aspects, EMTALA & Transport Ethics 13.2 Quality Improvement, Transport Safety Research & Evidence-Based Practice
4.1 Sepsis, Severe Sepsis & Septic Shock Resuscitation
Key Takeaways Explain This Topic AI
Sepsis-3 defines sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection, quantified by an acute increase in SOFA score ≥ 2 points.
The Surviving Sepsis Campaign 1-hour bundle mandates lactate measurement, blood cultures prior to broad-spectrum antibiotics, 30 mL/kg crystalloid bolus for hypotension or lactate ≥ 4 mmol/L, and immediate vasopressors to maintain MAP ≥ 65 mmHg.
Norepinephrine (0.02-3.0 mcg/kg/min) is the first-line vasopressor of choice; Vasopressin (0.03 units/min fixed dose) is the preferred second-line non-titrated adjunct.
Dobutamine (2.5-20 mcg/kg/min) is indicated for persistent myocardial dysfunction or hypoperfusion despite adequate volume resuscitation and MAP achievement.
Serial lactate clearance tracking (≥ 10-20% reduction every 2 hours) is a vital surrogate marker for successful tissue reperfusion during transport.
Last updated: July 2026
- 4.1 Sepsis, Severe Sepsis & Septic Shock Resuscitation
- Introduction & Evolving Definitions (Sepsis-2 vs Sepsis-3)
Sepsis is one of the most critical time-sensitive emergencies encountered in transport medicine. Historically, sepsis was conceptualized under the Sepsis-2 guidelines (2001) as a continuum beginning with Systemic Inflammatory Response Syndrome ( SIRS ), progressing to severe sepsis, and escalating to septic shock. SIRS required meeting at least two of four criteria: temperature > 38.0 ∘ C > 38.0^\circ\text{C} > 38. 0 ∘ C or < 36.0 ∘ C < 36.0^\circ\text{C} < 36. 0 ∘ C , heart rate > 90 beats/min > 90\text{ beats/min} > 90 beats/min , respiratory rate > 20 breaths/min > 20\text{ breaths/min} > 20 breaths/min (or PaCO 2 < 32 mmHg \text{PaCO}_2 < 32\text{ mmHg} PaCO 2 < 32 mmHg ), and white blood cell count > 12 , 000 / μ L > 12,000/\mu\text{L} > 12 , 000/ μ L , < 4 , 000 / μ L < 4,000/\mu\text{L} < 4 , 000/ μ L , or > 10 % > 10\% > 10% immature band forms.
In 2016, the Sepsis-3 Consensus Definitions fundamentally redefined sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection . Sepsis-3 eliminated the term "severe sepsis" and retired SIRS as a primary diagnostic criteria due to its poor specificity. Organ dysfunction is now objectively defined as an acute change in total Sequential Organ Failure Assessment (SOFA) score of ≥ 2 \ge 2 ≥ 2 points attributable to the infection.
Sequential Organ Failure Assessment (SOFA) & quick SOFA (qSOFA)
The SOFA score evaluates six organ systems, grading each from 0 (normal) to 4 (severely dysfunctional):
- Respiration : PaO 2 / FiO 2 \text{PaO}_2 / \text{FiO}_2 PaO 2 / FiO 2 ratio ( mmHg \text{mmHg} mmHg )
- Coagulation : Platelet count ( × 10 3 / μ L \times 10^3 / \mu\text{L} × 1 0 3 / μ L )
- Liver : Total bilirubin ( mg/dL \text{mg/dL} mg/dL )
- Cardiovascular : Mean Arterial Pressure (MAP) or vasopressor requirements
- Central Nervous System : Glasgow Coma Scale (GCS) score
- Renal : Serum creatinine ( mg/dL \text{mg/dL} mg/dL ) or daily urine output ( mL/day \text{mL/day} mL/day )
At the bedside or during pre-hospital and interfacility triage, the quick SOFA (qSOFA) serves as a rapid screening tool to identify patients outside the ICU who are at high risk of deterioration. A qSOFA score of ≥ 2 \ge 2 ≥ 2 points indicates high risk:
- Respiratory Rate : ≥ 22 breaths/min \ge 22\text{ breaths/min} ≥ 22 breaths/min
- Altered Mental Status : GCS < 15 \text{GCS} < 15 GCS < 15
- Systolic Blood Pressure : ≤ 100 mmHg \le 100\text{ mmHg} ≤ 100 mmHg
- Septic Shock Definition
Septic shock represents a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality. Under Sepsis-3, septic shock is clinically identified by persistent hypotension requiring vasopressors to maintain a MAP ≥ 65 mmHg \text{MAP} \ge 65\text{ mmHg} MAP ≥ 65 mmHg AND a serum lactate level > 2.0 mmol/L > 2.0\text{ mmol/L} > 2.0 mmol/L despite adequate volume resuscitation.
Comparison of Sepsis Frameworks
- Criteria / Parameter Sepsis-2 (2001) Sepsis-3 (2016)
- Core Concept Inflammatory cascade continuum (SIRS) Dysregulated host response resulting in organ dysfunction
- Screening Tool SIRS criteria ( ≥ 2 \ge 2 ≥ 2 required) qSOFA ( ≥ 2 \ge 2 ≥ 2 criteria) for bedside triage
- Organ Dysfunction Metric Clinical judgment / organ failure signs SOFA score increase of ≥ 2 \ge 2 ≥ 2 points
- Severe Sepsis Category Sepsis + Organ Dysfunction Deprecated (Subsumed under Sepsis definition)
Septic Shock Definition Sepsis-induced hypotension refractory to fluid resuscitation Vasopressor requirement for MAP ≥ 65 mmHg \text{MAP} \ge 65\text{ mmHg} MAP ≥ 65 mmHg AND Lactate > 2.0 mmol/L > 2.0\text{ mmol/L} > 2.0 mmol/L post-resuscitation
Surviving Sepsis Campaign (SSC) 1-Hour Bundle
The Surviving Sepsis Campaign (SSC) emphasizes immediate resuscitation. The 1-Hour Bundle outlines five actionable steps that must be initiated immediately upon recognition of sepsis or septic shock:
Measure Serum Lactate : Measure initial lactate level. If lactate is > 2.0 mmol/L > 2.0\text{ mmol/L} > 2.0 mmol/L , re-measure within 2-4 hours to guide lactate clearance tracking.
Obtain Blood Cultures Prior to Antibiotics : Draw at least two sets of blood cultures (aerobic and anaerobic)—one set peripherally and one through each vascular access device present > 48 hours > 48\text{ hours} > 48 hours . Do not delay antimicrobial administration by more than 45 minutes if culture procurement is difficult.
Administer Broad-Spectrum Antibiotics : Initiate empiric IV broad-spectrum antimicrobials covering all likely bacterial/fungal pathogens (e.g., Vancomycin combined with Cefepime, Piperacillin-Tazobactam, or Meropenem).
Administer 30 mL/kg 30\text{ mL/kg} 30 mL/kg Crystalloid Bolus : Rapidly infuse a minimum of 30 mL/kg 30\text{ mL/kg} 30 mL/kg of balanced crystalloid solution (e.g., Lactated Ringer's or Plasma-Lyte) within the first 3 hours for hypotension ( SBP < 90 mmHg \text{SBP} < 90\text{ mmHg} SBP < 90 mmHg , MAP < 65 mmHg \text{MAP} < 65\text{ mmHg} MAP < 65 mmHg ) or initial lactate ≥ 4.0 mmol/L \ge 4.0\text{ mmol/L} ≥ 4.0 mmol/L .
Apply Vasopressors : Initiate vasopressors during or immediately following fluid resuscitation if MAP remains < 65 mmHg < 65\text{ mmHg} < 65 mmHg to restore organ perfusion.
Fluid Resuscitation & Crystalloid Selection
Volume expansion restores intravascular filling pressures, increases mean systemic filling pressure, and boosts cardiac output via the Frank-Starling mechanism. Modern critical care mandates using balanced crystalloids (Lactated Ringer's or Plasma-Lyte) rather than 0.9 % 0.9\% 0.9% Normal Saline. High-volume 0.9 % 0.9\% 0.9% Normal Saline causes hyperchloremic metabolic acidosis, renal vasoconstriction, and increased risk of acute kidney injury (AKI) and renal replacement therapy.
Fluid responsiveness must be reassessed continuously using dynamic hemodynamic parameters rather than static CVP. Dynamic indicators include:
Passive Leg Raise (PLR) : Transiently increases preload by ∼ 300 mL \sim 300\text{ mL} ∼ 300 mL ; an increase in stroke volume or pulse pressure > 10 % > 10\% > 10% indicates fluid responsiveness.
Stroke Volume Variation (SVV) / Pulse Pressure Variation (PPV) : Values > 12 − 15 % > 12-15\% > 12 − 15% in mechanically ventilated patients with fixed tidal volumes ( 8 mL/kg 8\text{ mL/kg} 8 mL/kg ) indicate fluid responsiveness.
Hemodynamic Titration & Vasoactive Management
When 30 mL/kg 30\text{ mL/kg} 30 mL/kg fluid boluses fail to maintain a MAP ≥ 65 mmHg \text{MAP} \ge 65\text{ mmHg} MAP ≥ 65 mmHg , vasoactive infusions are titrated immediately.
First-Line Vasopressor: Norepinephrine
Norepinephrine is the first-line vasopressor in septic shock. It is a potent α 1 \alpha_1 α 1 -agonist with modest β 1 \beta_1 β 1 -adrenergic activity. It increases MAP primarily through arterial venoconstriction and systemic vascular resistance (SVR) elevation while providing mild inotropic support without marked tachycardia.
Dosing : 0.02 − 3.0 mcg/kg/min 0.02 - 3.0\text{ mcg/kg/min} 0.02 − 3.0 mcg/kg/min (or 2 − 30 mcg/min 2 - 30\text{ mcg/min} 2 − 30 mcg/min titrated to MAP ≥ 65 mmHg \text{MAP} \ge 65\text{ mmHg} MAP ≥ 65 mmHg ).
Second-Line Vasopressor: Vasopressin
Vasopressin (Antidiuretic Hormone) acts on vascular V 1 V_1 V 1 receptors to induce vascular smooth muscle contraction. Sepsis leads to endogenous vasopressin depletion. Vasopressin is added to norepinephrine to either increase MAP or reduce norepinephrine dosage requirements ("norepinephrine-sparing effect").
Dosing : Fixed non-titrated dose of 0.03 units/min 0.03\text{ units/min} 0.03 units/min . Do not titrate vasopressin for MAP management ; high doses ( > 0.03 − 0.04 units/min > 0.03-0.04\text{ units/min} > 0.03 − 0.04 units/min ) cause severe splanchnic and coronary vasoconstriction.
Inotropic Support: Dobutamine
If the patient exhibits persistent hypoperfusion (elevated lactate, low central venous oxygen saturation ScvO 2 < 70 % \text{ScvO}_2 < 70\% ScvO 2 < 70% , or low cardiac index) despite adequate volume resuscitation and MAP restoration, myocardial dysfunction ("septic cardiomyopathy") should be suspected. Dobutamine is a predominant β 1 \beta_1 β 1 -agonist with mild β 2 \beta_2 β 2 vasodilator properties.
Dosing : 2.5 − 20 mcg/kg/min 2.5 - 20\text{ mcg/kg/min} 2.5 − 20 mcg/kg/min continuous infusion. It enhances myocardial contractility and stroke volume.
Third-Line & Refractory Agents
Epinephrine : Added to norepinephrine or used as second-line agent when additional inotropic and vasoconstrictive support is required ( 0.05 − 0.5 mcg/kg/min 0.05 - 0.5\text{ mcg/kg/min} 0.05 − 0.5 mcg/kg/min ). Note that epinephrine causes transient increases in serum lactate via skeletal muscle β 2 \beta_2 β 2 -glycolysis.
Phenylephrine : Pure α 1 \alpha_1 α 1 -agonist. Reserved only for patients where norepinephrine induces severe tachyarrhythmias or when cardiac output is known to be elevated.
Vasoactive Infusion Reference Guide
Drug Target Receptors Primary Action Standard Dosing Range Clinical Indication
Norepinephrine α 1 > β 1 \alpha_1 > \beta_1 α 1 > β 1 Vasoconstriction + mild inotropy 0.02 − 3.0 mcg/kg/min 0.02 - 3.0\text{ mcg/kg/min} 0.02 − 3.0 mcg/kg/min 1st-line agent for septic shock
Vasopressin V 1 V_1 V 1 receptors Smooth muscle vasoconstriction 0.03 units/min 0.03\text{ units/min} 0.03 units/min fixed 2nd-line adjunct (non-titrated)
Dobutamine β 1 > β 2 \beta_1 > \beta_2 β 1 > β 2 Inotropy + mild vasodilation 2.5 − 20 mcg/kg/min 2.5 - 20\text{ mcg/kg/min} 2.5 − 20 mcg/kg/min Myocardial dysfunction / low ScvO 2 \text{ScvO}_2 ScvO 2
Epinephrine α 1 , β 1 , β 2 \alpha_1, \beta_1, \beta_2 α 1 , β 1 , β 2 Inotropy + vasoconstriction 0.05 − 0.5 mcg/kg/min 0.05 - 0.5\text{ mcg/kg/min} 0.05 − 0.5 mcg/kg/min Refractory shock / added to norepinephrine
Phenylephrine Pure α 1 \alpha_1 α 1 Pure arterial vasoconstriction 0.5 − 5.0 mcg/kg/min 0.5 - 5.0\text{ mcg/kg/min} 0.5 − 5.0 mcg/kg/min Norepinephrine-induced tachyarrhythmias
Transport Monitoring & Re-evaluation
During critical care transport of the septic patient, monitor:
Arterial Catheterization : Continuous invasive BP monitoring is mandatory due to non-invasive cuff inaccuracy in severe vasoconstriction.
Lactate Clearance Tracking : Serial lactate levels every 2-4 hours. Successful resuscitation is marked by a ≥ 10 − 20 % \ge 10-20\% ≥ 10 − 20% lactate clearance every 2 hours, reflecting resolution of tissue hypoxia.
Central Venous Oxygen Saturation ( ScvO 2 \text{ScvO}_2 ScvO 2 ) : Target ScvO 2 ≥ 70 % \text{ScvO}_2 \ge 70\% ScvO 2 ≥ 70% (or mixed venous SvO 2 ≥ 65 % \text{SvO}_2 \ge 65\% SvO 2 ≥ 65% ).
Urine Output : Target ≥ 0.5 mL/kg/hr \ge 0.5\text{ mL/kg/hr} ≥ 0.5 mL/kg/hr via indwelling Foley catheter with urometer.
Mechanical Ventilation : Implement lung-protective ventilation ( 6 mL/kg 6\text{ mL/kg} 6 mL/kg ideal body weight, plateau pressure P plat ≤ 30 cmH 2 O P_{\text{plat}} \le 30\text{ cmH}_2\text{O} P plat ≤ 30 cmH 2 O ) for secondary ARDS. Avoid hyperventilation which reduces venous return.